Novamine

The full engagement: from concept to lab, to your owned IP.

Novacore and Geode deliver a stripped back essence of Novamine. A full Novamine engagement delivers the complete R&D pipeline that runs a single challenge over 24 hours of compute and thousands of iterations.

We pair the architecture with your specialists to meticulously calibrate your brief. The engine’s output is then subjected to an agentic red team that systematically attacks every claim. Only the mathematically defended theses survive, arriving to you as a testable, lab-ready program.

Executed under strict NDA, with all intellectual property registered and assigned exclusively to you.

Precedent cannot outmanoeuvre the market.In high-stakes science & strategy, professionals confuse consensus with safety. But if every agency, firm, and lab is looking at the exact same data and generating the exact same median response, consensus is a vulnerability.

Breakthroughs do not live in the historical record. To gain an asymmetric advantage, you must cross the threshold into measurable, mathematically hardened novelty.

Why Novelty Matters in Your Sector

Every organisation now has the same AI, so every organisation gets the same derivative consensus answers. Novamine is the full engagement: the engine built to surface verifiably novel mechanisms, positions and moves, plus the sector specialists, the adversarial red team and the human-in-the-loop process that turn them into a programme your team can run and own. Here is why that matters in your field:

SectorThe Baseline (Standard AI)The Novamine Advantage
Science and R&DThe consensus hypothesis, already in the literature. A year spent confirming what the field expected.Up to twenty candidate mechanisms the consensus model never surfaces, each with its decisive experiment, synthesis route and pass or fail criteria, red-teamed by the adversarial network and checked against the patent landscape, then walked into the lab with our specialists beside your team: a year of confirming the expected replaced by one targeted trial, as with the ALS drug pairing now in funded trials at the Euan MacDonald Centre.
Finance and InvestingThe crowd's thesis, already in the price. More research to read, no decision to make.Contrarian theses the crowd has not written yet, each built to survive it: mechanism, catalysts, the numbers traced to their source, the kill criteria stated, attacked by the adversarial network until only the defended ones remain. What arrives is a decision memo an investment committee can act on, with our analysts on the call, not a pile to read.
StrategyYour competitors asked the same AI. The decks read the same, and so do the moves.The move your competitors have no ready answer to, which by definition is the move their consensus AI never suggests, worked through to the operating plan: actors, sequencing, the capital it needs, the response it provokes and the evidence that would prove it wrong, red-teamed and rehearsed with our specialists before it reaches the board.
Insurance and Private EquityThe known risks, listed well. The unpriced ones stay unnamed, because nobody asked for what was not on the list.The exposures and opportunities nobody has priced yet, found across the whole portfolio and worked into pricing logic your actuaries can test, with the mechanism, the data that would confirm it and the tripwires that would mean it is wrong, hardened by the adversarial network and walked through with your analysts before the market moves.
Engage Novamine five steps, from the first call to owned IP

There is no demo for the full engagement, because the engagement is the product: our people set the brief with you, the engine and the red team do the work, and you take away theses you own. It runs in five steps.

  1. Sign the NDA. Every engagement is protected under a strict NDA. Your proprietary data is never retained or reused.
  2. A recorded scoping call. We agree the challenge, the constraints and the pass or fail criteria with you, live, before any work begins, so the scope is evidenced rather than remembered.
  3. Agree IP retention. Exclusive transfer to you, shared ownership on agreed terms, or free discovery where Novamine keeps the IP and you keep the insight. The package price depends on the route.
  4. First run, iterative. The engine and our specialists produce the first set of theses. You challenge them; we harden them and run again.
  5. Second or third run, the final exchange. The surviving theses, each with its mechanism, its decisive experiment and a testable validation roadmap, registered and timestamped before delivery and assigned on the agreed terms.

What comes with Novamine

  • Up to 20 verifiable novel theses per engagement, free of precedent and prior art: IP-ready
  • Each with its mechanism, its decisive experiment and a testable validation roadmap
  • Every claim red-teamed by the adversarial network until only the defended ones survive, with our people in the loop
  • Sector and technical specialists who set the brief with you and stand behind the science with your team
  • Human-in-the-loop from concept to lab: hypotheses tested against expertise, experimental reality and commercial viability
  • Generated IP transferred exclusively to you or licensed on agreed terms; from £10,000 ($13,500) per engagement, dependent on IP retention
Speak to us a line is enough to start

Tell us where to reach you and, if you like, the shape of the problem. We will be in touch.